Neuronetics, INC Form 4 insider transactions

William Andrew Macan, an executive at Neuronetics, sold 12,175 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.

William Andrew Macan, an executive at Neuronetics, sold 1,970 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.

Neuronetics CEO Keith J. Sullivan sold 40,992 shares of common stock on February 10, 2025, to satisfy tax withholding obligations related to vesting of restricted stock units.

Stephen Furlong, EVP, CFO and Treasurer of Neuronetics, Inc., sold 14,836 shares of common stock on February 10, 2025, to cover tax withholding obligations.

Director Sheryl L Conley purchased 44,444 shares of Neuronetics, Inc. common stock at $2.25 per share in a firm commitment underwritten offering.

Director Glenn Muir purchased 44,444 shares of Neuronetics (STIM) common stock at $2.25 per share on February 7, 2025, increasing his total holdings.

Director Sasha Cucuz recently purchased 88,888 shares of Neuronetics, Inc. common stock at $2.25 per share, increasing their total holdings.

Director Robert Cascella increases his holdings in Neuronetics, Inc. (STIM) with a purchase of 88,888 shares at $2.25 per share.

Neuronetics CEO Keith J. Sullivan was granted 450,000 performance-based restricted stock units (PRSUs) that vest upon achieving cash flow breakeven targets in 2025.

William Andrew Macan, an executive at Neuronetics, Inc., was granted 135,000 performance-based restricted stock units (PRSUs) that vest upon achieving specific cash flow breakeven targets.

Stephen Furlong, EVP, CFO and Treasurer of Neuronetics, Inc., was granted 150,000 performance-based restricted stock units (PRSUs) that vest upon achieving cash flow breakeven targets.

Stephen Furlong, EVP, CFO, and Treasurer of Neuronetics, Inc., sold 1,368 shares of common stock on October 8, 2024, to satisfy tax withholding obligations upon vesting of a restricted stock unit award.

William Andrew Macan, EVP, GC, CCO and CS of Neuronetics, Inc., sold 1,541 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.

Director Robert Casella purchased 100,000 shares of Neuronetics, Inc. common stock at $0.75 per share on September 12, 2024.

Director Glenn P. Muir purchased 25,000 shares of Neuronetics, Inc. common stock at $0.80 per share on September 5, 2024.

Glenn P. Muir, a director at Neuronetics, Inc., has increased his holdings in the company through recent stock purchases.

Director Glenn P. Muir of Neuronetics, Inc. (STIM) acquired 25,000 shares of common stock at $1 per share on August 20, 2024, increasing his total holdings to 239,818 shares.

Director Robert Cascella of Neuronetics, Inc. (STIM) has increased his holdings through open market purchases of common stock.

Director Robert Cascella recently purchased 70,000 shares of Neuronetics, Inc. common stock in two separate transactions.

Director Glenn P. Muir increased his holdings in Neuronetics, Inc. by purchasing 25,171 shares of common stock at $0.75 per share on August 14, 2024.

Neuronetics CEO Keith J. Sullivan sold 24,162 shares of common stock on July 18, 2024, to satisfy tax withholding obligations related to vesting of restricted stock units.

Neuronetics CEO Keith J. Sullivan sold a portion of his common stock holdings to satisfy tax withholding obligations related to the vesting of restricted stock units.

Director Robert Cascella purchased 50,000 shares of Neuronetics, Inc. at $2.051 per share, increasing his holdings.

Director Robert Cascella acquired 31,250 restricted stock units in Neuronetics, Inc.

Director Sheryl Conley of Neuronetics, Inc. reports the acquisition of 25,000 restricted stock units (RSUs) on May 30, 2024.

Neuronetics Director Megan Rosengarten reports the acquisition of 25,000 restricted stock units (RSUs) in a recent SEC filing.

Glenn Muir, a director at Neuronetics, Inc., acquired 25,000 restricted stock units (RSUs) on May 30, 2024, according to a recent SEC Form 4 filing.

William Andrew Macan, EVP, GC, CCO and CS of Neuronetics, Inc., reports selling shares to cover tax obligations and receiving a new restricted stock unit (RSU) award.

Stephen Furlong, EVP, CFO and Treasurer of Neuronetics, Inc., reports acquiring 15,000 shares of common stock through a restricted stock unit award.

Stephen Furlong, EVP, CFO and Treasurer of Neuronetics, Inc., sold shares of common stock on February 27 and 28, 2024, to satisfy tax withholding obligations related to vesting restricted stock units.